BioLife Solutions Inc. vs. Neuraxis, Inc.
BioLife Solutions Inc. (BLFS) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| BLFS | NRXS | |
|---|---|---|
| Market Cap | $1.77 billion | $87.15 million |
| Revenue (TTM) | $102.82 million | $5.32 million |
| Net Income (TTM) | $57.98 million | $-7,678,631 |
BLFS leads on 3 of 3 size & scale factors.
Valuation
| BLFS | NRXS | |
|---|---|---|
| P/E Ratio | 30.60 | — |
| Price / Book | 4.21 | 12.94 |
| Price / Sales | 17.18 | 16.39 |
BLFS and NRXS split the valuation factors evenly.
Profitability
| BLFS | NRXS | |
|---|---|---|
| Net Margin | 56.39% | -144.44% |
| Return on Equity | 13.80% | -114.01% |
BLFS leads on 2 of 2 profitability factors.
Risk & Sentiment
| BLFS | NRXS | |
|---|---|---|
| Short Interest | 1.61% | 0.02% |
NRXS leads on 1 of 1 risk & sentiment factors.
Dig deeper: BLFS overview, BLFS financials, NRXS overview, NRXS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.